Cyclin-dependent protein serine/threonine kinase inhibitors as anticancer drugs

R Roskoski Jr - Pharmacological research, 2019 - Elsevier
Cyclins and cyclin-dependent protein kinases (CDKs) are important proteins that are
required for the regulation and expression of the large number of components necessary for …

Structural insights into the functional diversity of the CDK–cyclin family

DJ Wood, JA Endicott - Open biology, 2018 - royalsocietypublishing.org
Since their characterization as conserved modules that regulate progression through the
eukaryotic cell cycle, cyclin-dependent protein kinases (CDKs) in higher eukaryotic cells are …

Lactate regulates cell cycle by remodelling the anaphase promoting complex

W Liu, Y Wang, LHM Bozi, PD Fischer… - Nature, 2023 - nature.com
Lactate is abundant in rapidly dividing cells owing to the requirement for elevated glucose
catabolism to support proliferation,,,,–. However, it is not known whether accumulated lactate …

Targeting cyclin-dependent kinase 1 (CDK1) in cancer: molecular docking and dynamic simulations of potential CDK1 inhibitors

S Sofi, U Mehraj, H Qayoom, S Aisha, A Almilaibary… - Medical Oncology, 2022 - Springer
Cell cycle dysregulation is a characteristic hallmark of malignancies, which results in
uncontrolled cell proliferation and eventual tumor formation. Cyclin-dependent kinase 1 …

Improving protein-protein interactions prediction accuracy using XGBoost feature selection and stacked ensemble classifier

C Chen, Q Zhang, B Yu, Z Yu, PJ Lawrence… - Computers in biology …, 2020 - Elsevier
Protein-protein interactions (PPIs) are involved with most cellular activities at the proteomic
level, making the study of PPIs necessary to comprehending any biological process …

Expanding control of the tumor cell cycle with a CDK2/4/6 inhibitor

K Freeman-Cook, RL Hoffman, N Miller, J Almaden… - Cancer cell, 2021 - cell.com
Summary The CDK4/6 inhibitor, palbociclib (PAL), significantly improves progression-free
survival in HR+/HER2− breast cancer when combined with anti-hormonals. We sought to …

Inhibition of the CDK2 and Cyclin A complex leads to autophagic degradation of CDK2 in cancer cells

J Zhang, Y Gan, H Li, J Yin, X He, L Lin, S Xu… - Nature …, 2022 - nature.com
Abstract Cyclin-dependent kinase 2 (CDK2) complex is significantly over-activated in many
cancers. While it makes CDK2 an attractive target for cancer therapy, most inhibitors against …

Structural basis of human separase regulation by securin and CDK1–cyclin B1

J Yu, P Raia, CM Ghent, T Raisch, Y Sadian… - Nature, 2021 - nature.com
In early mitosis, the duplicated chromosomes are held together by the ring-shaped cohesin
complex. Separation of chromosomes during anaphase is triggered by separase—a large …

Cyclin-dependent protein kinase inhibitors including palbociclib as anticancer drugs

R Roskoski Jr - Pharmacological research, 2016 - Elsevier
Cyclins and cyclin-dependent protein kinases (CDKs) are important regulatory components
that are required for cell cycle progression. The levels of the cell cycle CDKs are generally …

Discovery of thiazole-based-chalcones and 4-hetarylthiazoles as potent anticancer agents: Synthesis, docking study and anticancer activity

TA Farghaly, GS Masaret, ZA Muhammad… - Bioorganic chemistry, 2020 - Elsevier
The crucial need for novel antitumor agents with high selectivity toward cancer cells has
promoted us to synthesize new series of thiazole-based chalcones and 4-hetarylthiazoles …